- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01042171
Evaluation of Image Quality Over Time After Injection of the fluorescein Sodium for Confocal Laser Endomicroscopy
July 17, 2012 updated by: Yanqing Li, Shandong University
Confocal laser endomicroscopy (CLE) is a newly developed endoscopic technique.
The most commonly used fluorescent substance is Fluorescein sodium.The plasma half-life of fluorescein is 11 minutes.
A recent test estimated that fluorescein-based CLSM(confocal laser scanning microscopy) of the upper-GI tract of pigs delivers the best contrast and image quality within the first 8 minutes after injection of fluorescein .However, despite its increasing use in clinical examination,there are no data on contrast dynamics and image quality over time after injection of the fluorescein sodium in the inspection of gastrointestinal tract of human being.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
20
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Shandong
-
Jinan, Shandong, China, 250012
- Department of Gastroenterology, Qilu Hospital, Shandong University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
patients without any disease of heart,liver or kidney;patients without serious gastritis and other serious stomach lesions.
Description
Inclusion Criteria:
- These subjects will include male or female aged between 18 and 60 years with indications for upper-endoscopy ,but without serious gastritis and other serious stomach lesions
Exclusion Criteria:
- Complications such as gastric and/or duodenal peptic ulcer, stenosis
- Esophageal, gastric or duodenal cancer or other malignancy
- History of stomach surgery
- A history of bronchial asthma, or known allergy to fluorescein.
- Pregnant or breast-feeding (for females)
- Below 18 or above 60 years of age
- Severe comorbidities ( e.g. such as renal failure, congestive cardiac failure, liver cirrhosis).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The ideal time period for the best CLE imaging when using fluorescein sodium is about 10 minutes
Time Frame: Within the 30 minutes after injection of fluorescein
|
Within the 30 minutes after injection of fluorescein
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Yanqing Li, PhD. MD., Department of Gastroenterology, Qilu Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2009
Primary Completion (Actual)
June 1, 2010
Study Completion (Actual)
June 1, 2010
Study Registration Dates
First Submitted
January 4, 2010
First Submitted That Met QC Criteria
January 4, 2010
First Posted (Estimate)
January 5, 2010
Study Record Updates
Last Update Posted (Estimate)
July 18, 2012
Last Update Submitted That Met QC Criteria
July 17, 2012
Last Verified
July 1, 2012
More Information
Terms related to this study
Other Study ID Numbers
- 2009SDU-QILU-G07
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Change of Image Quality of CLE
-
Assistance Publique - Hôpitaux de ParisUnknownImpact of Self Assessment of Foetal Ultrasound Images on Image QualityFrance
-
Shandong UniversityUnknownImage Quality of Early Esophageal Squamous Neoplasia | Endoscopists'Subjective AssessmentsChina
-
Norwegian School of Sport SciencesUniversity of Agder; Ostfold University College; University College of Southeast...CompletedQuality of Life | Physical Activity | Dietary Habits | Body Image Disturbance | Body ImageNorway
-
Istanbul Arel Universitysanem sener Assoc. Prof. PhD.Enrolling by invitationQuality of Life | Motivation | Body ImageTurkey
-
GlycaNova ASOPIS USARecruitingChange in Mood | Change in PersonalityBulgaria
-
University of AlbertaCompleted
-
Philips HealthcareCompletedCompare Image Quality Between SDCT and Conventional CT Images of Any Tissue Lesion, Determine Optimal Monochromatic Energy Level for a Coronary Artery ImageUnited States
-
University of SheffieldCompletedQuality of Life | Psychological Distress | Body Image | Dermatologic DiseaseUnited Kingdom
-
George Mason UniversityNational Endowment for the Arts, United StatesCompletedQuality of Life | Physical Activity | Cognitive Impairment | Self-Perception | Social Isolation | Mental Status ChangeUnited States
-
University of ViennaUnknownChange of Gastric pHAustria